The Valvular Interventions Center

Filter Your Results

 

News

 

FDA Clears Claret Medical's Sentinel Cerebral Protection System for TAVR Procedures

June 5, 2017 -- Claret Medical, Inc. announced that it has received clearance from the US Food and Drug Administration (FDA) for the Sentinel cerebral protection system (CPS…

FDA Approves Expanded Indication for Use of Edwards Sapien 3 for Valve-in-Valve Treatment in High-Risk Patients

June 5, 2017 -- Edwards Lifesciences Corporation announced that it has received US Food and Drug Administration (FDA) approval for aortic and mitral valve-in-valve procedures …

High-Volume TAVR Hospitals Associated With Significantly Lower 30-Day Readmissions

June 2, 2017 -- An observational study of high-volume transcatheter aortic valve replacement (TAVR) hospitals versus medium- and low-volume TAVR hospitals was recently publish…

Data Presented From SURTAVI and NOTION Trials of TAVR

May 18, 2017 -- Findings from the randomized SURTAVI (Surgical Replacement and Transcatheter Aortic Valve Implantation) trial showed that patients at intermediate risk for sur…

Thirty-Day Outcomes Presented for Edwards' Centera TAVR Device

May 17, 2017 -- Edwards Lifesciences announced the first data on patients treated with the company's self-expanding Centera transcatheter aortic valve replacement (TA…

Medtronic's CoreValve and CoreValve Evolut R TAVR Systems Evaluated in Real-World Studies

May 16, 2017 -- Medtronic announced that new data on the company's self-expanding CoreValve platform were presented from the CoreValve ADVANCE and Evolut R FORWA…

One-Year REPRISE III Data Presented for Boston Scientific's Lotus TAVR System

May 16, 2017 -- Boston Scientific Corporation announced that results from the REPRISE III clinical trial were presented at the EuroPCR 2017 conference in Paris, France. A…

Boston Scientific Closes Symetis Acquisition

May 16, 2017 -- Boston Scientific Corporation announced the close of its acquisition of Symetis SA, a privately held Swiss structural heart company focused on transcatheter ao…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.